|
HSPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62647673107585E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.07850395281162E-11 |
| Normal-vs-Stage2 |
2.3181999999955E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
4.37229999983302E-08 |
| Stage1-vs-Stage2 |
4.720400E-01 |
| Stage1-vs-Stage3 |
5.147900E-02 |
| Stage1-vs-Stage4 |
7.153600E-01 |
| Stage2-vs-Stage3 |
3.829700E-02 |
| Stage2-vs-Stage4 |
7.089200E-01 |
| Stage3-vs-Stage4 |
4.764400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
4.560000E-04 |
| Normal-vs-Asian |
6.069600E-01 |
| Caucasian-vs-AfricanAmerican |
2.924000E-01 |
| Caucasian-vs-Asian |
1.264560E-01 |
| AfricanAmerican-vs-Asian |
3.733600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.82947015711943E-14 |
| Normal-vs-Female |
1.72906133855122E-12 |
| Male-vs-Female |
9.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.12339999817024E-08 |
| Normal-vs-Age(41-60Yrs) |
1.68176583770219E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
7.195600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.596400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.984200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.890000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.864050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.323000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.565400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.72003999999726E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.58320001553136E-09 |
| Normal-vs-Grade 4 |
9.40500000101707E-08 |
| Grade 1-vs-Grade 2 |
9.820600E-01 |
| Grade 1-vs-Grade 3 |
6.075800E-01 |
| Grade 1-vs-Grade 4 |
5.236800E-01 |
| Grade 2-vs-Grade 3 |
2.881200E-01 |
| Grade 2-vs-Grade 4 |
1.371560E-01 |
| Grade 3-vs-Grade 4 |
7.054000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.20958798532911E-12 |
| Normal-vs-ccB subtype |
6.5244000202469E-09 |
| ccA subtype-vs-ccB subtype |
3.268000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.033960E-01 |
| N0-vs-N1 |
1.429840E-01 |
|
|
